HMOX1 Attenuates the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib via Modulating the Expression of ABC Transporters
Hepatocellular carcinoma (HCC) represents a common malignancy, and mechanisms of acquired sorafenib resistance during the treatment of HCC patients remain elusive. The present study performed integrated bioinformatics analysis and explored the potential action of heme oxygenase 1 (HMOX1) in sorafeni...
Saved in:
| Main Authors: | Xian Zhu, Yinfang Zhang, Yafei Wu, Wenjing Diao, Guilong Deng, Qin Li, Chuanxing Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2022/9451557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma
by: Muhammad W. Saif, et al.
Published: (2011-01-01) -
Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
by: L. Barbier, et al.
Published: (2011-01-01) -
20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters
by: Yulin Wu, et al.
Published: (2025-07-01) -
Targeting SIX2 as a novel sensitization strategy of sorafenib treatment on advanced hepatocellular carcinoma through modulating METTL9-SLC7A11 axis
by: Junren Lu, et al.
Published: (2025-06-01) -
D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma
by: Silvia Pedretti, et al.
Published: (2025-06-01)